Brown Advisory Inc Astrazeneca PLC Transaction History

Brown Advisory Inc

$77.3 Billion
Q3 2024

A detailed history of Brown Advisory Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Brown Advisory Inc holds 14,500 shares of AZN stock, worth $1.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,500

Previous 14,143 2.52%

Holding current value

$1.02 Million

Previous $1.1 Million 2.36%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$76.67 - $87.62 $27,371 - $31,280	357 Added 2.52%	14,500 $1.13 Million
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $330,709 - $400,108	4,950 Added 53.85%	14,143 $1.1 Million
Q1 2024 Apr 24, 2024	BUY	$61.03 - $69.57 $23,313 - $26,575	382 Added 4.34%	9,193 $622,000
Q4 2023 Feb 08, 2024	SELL	$61.89 - $69.28 $55,824 - $62,490	-902 Reduced 9.29%	8,811 $593,000
Q3 2023 Oct 24, 2023	BUY	$64.85 - $71.7 $64,785 - $71,628	999 Added 11.46%	9,713 $657,000
Q2 2023 Jul 31, 2023	BUY	$69.91 - $75.81 $152,473 - $165,341	2,181 Added 33.38%	8,714 $623,000
Q1 2023 May 08, 2023	BUY	$63.15 - $71.6 $76,032 - $86,206	1,204 Added 22.59%	6,533 $453,000
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $19,190 - $24,935	-354 Reduced 6.23%	5,329 $361,000
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $5,991 - $15,339	113 Added 2.03%	5,683 $312,000
Q2 2022 Nov 14, 2022	SELL	$59.26 - $71.14 $49,541 - $59,473	-836 Reduced 13.05%	5,570 $368,000
Q2 2022 Aug 02, 2022	SELL	$59.26 - $71.14 $335,944 - $403,292	-5,669 Closed	0 $0
Q1 2022 Nov 14, 2022	BUY	$55.72 - $67.12 $356,942 - $429,970	6,406 New	6,406 $425,000
Q1 2022 Sep 13, 2022	BUY	$55.72 - $67.12 $315,876 - $380,503	5,669 New	5,669 $377,000
Q3 2021 Nov 12, 2021	SELL	$55.56 - $60.79 $352,194 - $385,347	-6,339 Closed	0 $0
Q2 2021 Jul 29, 2021	BUY	$48.42 - $60.18 $306,934 - $381,481	6,339 New	6,339 $380,000
Q3 2018 Nov 13, 2018	SELL	$34.76 - $39.72 $247,734 - $283,084	-7,127 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$34.55 - $37.05 $42,772 - $45,867	1,238 Added 21.02%	7,127 $250,000
Q1 2018 Jun 28, 2018	BUY	$32.97 - $36.63 $194,160 - $215,714	5,889 New	5,889 $206,000
Q1 2018 May 14, 2018	SELL	$32.97 - $36.63 $327,754 - $364,138	-9,941 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$32.09 - $34.78 $319,006 - $345,747	9,941	9,941 $345,000

Others Institutions Holding AZN

# of Institutions

1,334

Shares Held

476M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $218B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.

Account

Brown Advisory Inc Astrazeneca PLC Transaction History